1 insider bought shares over the last 90 days, the latest filed 08 Sept 2026.
This page follows insider dealings at OssDsign AB as filed with Finansinspektionen, a company from the Health Care sector based in Uppsala, Sweden. The group dates from 2011. Over the twelve months to 18 October 2026, 2 filings were filed, from 2 insiders.
Purchases and sales both appear in the filings: 1 purchase (1 insider) and 1 sale (1 insider, €8,463). The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a sale of €8,463 by Jill Schiaparelli, published on 15 November 2025, equal to 0.021% of the market capitalisation. Among those who bought: 1 chief executive.
Compared with its exchange (890 companies, median 7 filings), a count of 2 filings is below the norm. Our records for OssDsign AB go back to 2025, with 2 purchases and 4 sales on the open market in total.
The latest purchase dates back some time: it was published 39 days ago, on 8 September 2026.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Headquarters: Uppsala, Sweden · Founded: 2011
Source: Wikidata (CC0).
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate OssDsign AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 6.25.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
11 of 11 declarations
OssDsign AB is a company focused on developing innovative solutions for bone regeneration. It is listed on the Stockholm Stock Exchange.
Purchases our model currently ranks for the recommendations list.
All recommendations